Granulomas are a characteristic feature of Crohn's disease but the factors leading to their formation are unknown. In the absence of an identifiable specific antigen one possible explanation could be an underlying phagocyte defect leading to defective clearance of all foreign antigens in away analogous to chronic granulomatous disease of childhood.
Although phagocytosis1 2 and intracellular killing35 by neutrophils and monocytes are generally normal or enhanced in Crohn's disease, Segal and Loewi6 found a marked diminution of neutrophil chemotaxis into skin-window chambers containing the patient's own serum. Their results could be explained not only by an intrinsic defect in neutrophil chemotaxis or motility but also by the presence of serum inhibitors or abnormalities in vascular permeability or coagulation. It is, therefore, important to know whether the neutrophils move normally in the absence of serum.
Granulomas have been shown to arise from cells of the monocyte/macrophage series.7 It is possible, therefore, that Crohn's disease could also result from a defect in monocyte motility causing delayed clearance of foreign material from the gut mucosa. There has not previously been any published study of monocyte motility in Crohn's disease.
Ulcerative Binder and Riis18 and Hermanowicz and Nawarska'9 found that isolated neutrophils from patients with ulcerative colitis showed enhanced random motility, but reduced chemotaxis. In the present study a similar trend has been found, but this was not statistically significant. In both studies there is a very considerable overlap between the values obtained both for neutrophil random motility and chemotaxis in ulcerative colitis and normal controls. It therefore seems unlikely that there is any important underlying abnormality of neutrophil motility in ulcerative colitis. Monocyte chemotaxis is shown to be significantly enhanced in ulcerative colitis, but only by a small amount (<10%). The fact that random motility of the monocytes is also enhanced suggests that this apparent increase in chemotaxis is probably due to increased speed of cell movement (chemokinesis) rather than altered directional motility. The finding that increased monocyte chemotaxis correlates with increased activity of the ulcerative colitis suggests that it is probably secondary to the disease state. Previous work has shown that monocyte phagocytosis5 and monocyte lysosomal enzyme concentrations9 are also enhanced in active ulcerative colitis, so that the increase in monocyte motility may be a further indication that monocyte activation occurs during attacks of ulcerative colitis. It may well be that such activation of cells of the monocyte/ macrophage series with subsequent lysosomal enzyme release is responsible for some of the mucosal damage in ulcerative colitis.
There is also evidence of increased monocyte/macrophage activation5 9 and turnover20 in Crohn's disease. This study has failed to show a corresponding enhancement of monocyte motility in Crohn's disease, although casein-directed monocyte chemotaxis was slightly, albeit insignificantly, greater than that of control monocytes. It is interesting that therapy with either prednisolone or sulphasalazine had no effect on the chemotaxis of monocytes and neutrophils in vitro.
Two other studies have also shown that prednisolone therapy fails to affect neutrophil chemotaxis. 16 
